期刊文献+

一种雄烯二酮衍生物的合成及应用研究 被引量:1

Synthesis and Application of the Androstenedione Derivative
下载PDF
导出
摘要 目的:提供一种雄烯二酮衍生物的合成方法,并对该化合物的应用进行研究。方法:以依西美坦和多聚甲醛为原料,二甲胺盐酸盐为催化剂,一步反应制备得到目标化合物——6,16-二亚甲基雄甾-1,4-二烯-3,17-二酮,优化反应条件,并通过气相色谱-质谱、核磁共振等表征确认结构。同时,对该化合物的体外抗肿瘤活性进行实验,选用细胞株为胃癌细胞株(MKN45)、肺癌细胞(HCC-78)、人乳腺癌细胞(MDA-MB-231)、肝癌细胞(HepG2)、卵巢癌细胞(3AO)。结果:通过表征确认了目标化合物的结构,且该化合物对肿瘤细胞有抑制活性,其中对人乳腺癌细胞(MDA-MB-231)和卵巢癌细胞(3AO)抑制效果较好。结论:提供了一条操作简单、成本低、收率高的6,16-二亚甲基雄甾-1,4-二烯-3,17-二酮合成路线,该化合物对肿瘤细胞有明显的抑制作用。 Objective:To provide a synthesis method of androstenedione derivatives,and to study the application of this compound.Methods:Using exemestane and paraformaldehyde as raw materials and dimethylamine hydrochloride as catalyst,the target compound——6,16-dimethylandrost-1,4-diene-3,17-dione was prepared by one-step reaction.The reaction conditions were optimized,and the structure was confirmed by gas chromatography-mass spectrometry,nuclear magnetic resonance and other characterizations.At the same time,the in vitro antitumor activity of the compound was tested,and the selected cell lines were gastric cancer cell line(MKN45),lung cancer cell(HCC-78),human breast cancer cell(MDA-MB-231),liver cancer cell(HepG2),and ovarian cancer cells(3AO).Results:The structure of the target compound was confirmed by characterization,and the compound had inhibitory activity on tumor cells,among which the inhibitory effect on human breast cancer cells(MDA-MB-231)and ovarian cancer cells(3AO)was better.Conclusions:It provides a simple,low cost and high yield synthesis route of 6,16-methylandrostere-1,4-diene-3,17-dione,which has obvious inhibitory effect on tumor cells.
作者 查娟 潘晓军 李恩民 陈龙 章潮军 陈春峰 商甜波 罗艳娟 徐慧婷 ZHA Juan;PAN Xiao-jun;LI En-min;CHEN Long;ZHANG Chao-jun;CHEN Chun-feng;SHANG Tiao-bo;LUO Yan-juan;XU Hui-ting(Zhejiang Medicine Co.,Ltd.,Shaoxing,Zhejiang 31200,China;Zhejiang Engineering Research Center of Fat-soluble Vitamin,Shaoxing,Zhejiang 312000,China;College of Chemical Engineering,Shaoxing University,Shaoxing,Zhejiang 312000,China)
出处 《浙江化工》 CAS 2022年第6期19-23,共5页 Zhejiang Chemical Industry
关键词 乳腺癌 雄烯二酮衍生物 合成 抗肿瘤活性 breast cancer androstenedione derivative synthesis antitumor activity
  • 相关文献

参考文献9

二级参考文献159

  • 1徐积恩.抗肿瘤药 福美司坦[J].国外医药(合成药.生化药.制剂分册),1994,15(3):179-179. 被引量:1
  • 2陈琳,武正炎.NSABP乳腺癌临床试验的最新成果和应用前景[J].实用临床医药杂志,2006,10(2):12-17. 被引量:5
  • 3张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 4杨曼瑾 郭传勇.抗肿瘤药-依西美坦[J].国外医药合成药生化药制剂分册,2000,21(5):300-300.
  • 5KARKOLA S, WAHALA K. The binding of lignans, flavonoids and coumestrol to CYP450 aromatase: a molecular modelling study[J]. Mol Cell Endocrinol,2009,301 (1/2) :235 -244.
  • 6MONTEIRO R, FARIA A, AZEVEDO I, et al. Modulation of breast cancer cell survival by aromatase inhibiting hop ( Humulus lupulus L. ) flavonoids [J]. J Steroid Biochem Mol Biol,2007,105(1/5) : 124 - 130.
  • 7POUGET C,FAGNERE C,BASLY J,et al. Design, synthesis and evaluation of 4-imidazolylflavans as new leads for aromatase inhibition [ J ]. Bioorg Med Chem Lett,2002,12 (20) :2859 - 2861.
  • 8POUGET C, YAH/AOUI S, FAGNERE C, et al. Synthesis and biological evaluation of 4-imidazolylfiavans as nonstemidal aromatase inhibitors [ J ]. Bioorg Chem,2004,32 (6) :494 - 503.
  • 9RECANATINI M, BISI A, CAVALLI A, et al. A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromonc and xanthonc derivatives and inhibition of the P450 enzymes aromatasc and 17α-hydroxylasc/C17,20-1yase [ J ]. J Med Chem ,2001,44 (5) :672 - 680.
  • 10HACKEIT J, KIM Y, SU B, et al. Synthesis and characterization of azole isoflavonc inhibitors of aromatasc[ J]. Bioorg Med Chcm, 2005, 13 ( 12 ) : 4063 - 4070.

共引文献66

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部